Suppr超能文献

男性至女性重建手术后新阴道鳞状细胞癌:一例报告并文献复习

Squamous Carcinoma of the Neovagina after Male-to-Female Reconstruction Surgery: A Case Report and Review of the Literature.

作者信息

Fierz Ronja, Ghisu Gian-Piero, Fink Daniel

机构信息

Department of Gynaecology, University Hospital Zurich, Zurich, Switzerland.

出版信息

Case Rep Obstet Gynecol. 2019 Jan 16;2019:4820396. doi: 10.1155/2019/4820396. eCollection 2019.

Abstract

Squamous cell carcinoma (SCC) of the neovagina after genital reconstruction surgery is a rare occurrence with only very few cases published up to the present. We report a case of a 43-year-old transgender woman who developed neovaginal SCC 23 years after vaginoplasty. The patient tested positive for high-risk human papillomavirus (HPV). At the time of diagnosis, radiological investigations revealed already existing lymph node and osseous metastases. The treatment consisted of various cycles of chemotherapy and radiation therapy. Unfortunately, the formation of additional metastases, including cerebral, pulmonary, and hepatic metastases, could not be prevented. After comparing the literature on the topic, we conclude that neovaginal carcinoma often appears years and decades after genital reconstruction surgery. We therefore recommend the continuation of regular clinical follow-up for transgender women after postoperative follow-up is completed. With this approach, potential lesions may be detected at an earlier stage and a better outcome may be achieved. Follow-up should include neovaginal examination and cytological smear testing. At a later age, we recommend additional regular prostate-specific antigen (PSA) testing and digital rectal examination (DRE). Moreover, transgender women are advised to take part in mammography screening starting at the age of 50, especially when additional risk factors are present.

摘要

生殖器重建手术后新阴道鳞状细胞癌(SCC)是一种罕见的情况,迄今为止仅有极少数病例报道。我们报告一例43岁的跨性别女性,在阴道成形术后23年发生了新阴道SCC。该患者高危人乳头瘤病毒(HPV)检测呈阳性。在诊断时,影像学检查显示已有淋巴结和骨转移。治疗包括多个周期的化疗和放疗。不幸的是,包括脑、肺和肝转移在内的额外转移无法预防。在比较了该主题的文献后,我们得出结论,新阴道癌通常在生殖器重建手术后数年甚至数十年出现。因此,我们建议在跨性别女性术后随访完成后继续进行定期临床随访。通过这种方法,潜在病变可能在更早阶段被检测到,从而可能获得更好的结果。随访应包括新阴道检查和细胞学涂片检测。在年龄较大时,我们建议额外定期进行前列腺特异性抗原(PSA)检测和直肠指检(DRE)。此外,建议跨性别女性从50岁开始参加乳腺钼靶筛查,尤其是存在其他风险因素时。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f748/6354136/dc5c25b4cf51/CRIOG2019-4820396.001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验